Advancements of antisense oligonucleotides in treatment of breast cancer - PubMed (original) (raw)
Affiliations
- PMID: 12676065
Free article
Review
Advancements of antisense oligonucleotides in treatment of breast cancer
Shuan-Ping Yang et al. Acta Pharmacol Sin. 2003 Apr.
Free article
Abstract
Breast cancer is one kind of multi-gene related malignancy. Overexpression of some oncogenes such as HER-2 (c-erbB-2, Neu), bcl-2/bcl-xL, protein kinase A (PKA), and transferrin receptor gene (TfR gene), etc significantly affect the prognosis of breast cancer. It was shown that specific suppression of the overexpressed genes above resulted in the improvement of the therapy of breast cancer. Antisense interference, one of useful tools for inhibiting the overexpression of specific oncogenes, was involved in the therapy of breast cancer in recent years. Data indicated that antisense oligonucleotides (ON) could inhibit specially the expression of the target genes on mRNA or protein levels in most of cases; some ON candidates showed encouraging therapeutic effects in vitro and in vivo on breast cancer cell lines or xenografts. Furthermore, the combination use of the antisense ON and normal chemotherapeutic agents indicated synergistic antitumor effects, which was probably the best utilization of antisense ON in the treatment of breast cancer.
Similar articles
- Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer.
Rait AS, Pirollo KF, Rait V, Krygier JE, Xiang L, Chang EH. Rait AS, et al. Cancer Gene Ther. 2001 Oct;8(10):728-39. doi: 10.1038/sj.cgt.7700359. Cancer Gene Ther. 2001. PMID: 11687896 - HER2/neu antisense targeting of human breast carcinoma.
Roh H, Pippin JA, Green DW, Boswell CB, Hirose CT, Mokadam N, Drebin JA. Roh H, et al. Oncogene. 2000 Dec 11;19(53):6138-43. doi: 10.1038/sj.onc.1204001. Oncogene. 2000. PMID: 11156527 Review. - CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS. Nesterova MV, et al. Clin Cancer Res. 2005 Aug 15;11(16):5950-5. doi: 10.1158/1078-0432.CCR-05-0624. Clin Cancer Res. 2005. PMID: 16115938 - Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
Witters LM, Witkoski A, Planas-Silva MD, Berger M, Viallet J, Lipton A. Witters LM, et al. Oncol Rep. 2007 Feb;17(2):465-9. Oncol Rep. 2007. PMID: 17203189 - Combined use of antisense oligonucleotides and chemotherapeutics in the treatment of refractory prostate cancer.
Baltogiannis D, Charalabopoulos K, Giannakopoulos X, Karakosta A, Sofikitis N. Baltogiannis D, et al. Exp Oncol. 2005 Jun;27(2):91-3. Exp Oncol. 2005. PMID: 15995623 Review.
Cited by
- Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer.
Fang H, Cavaliere A, Li Z, Huang Y, Marquez-Nostra B. Fang H, et al. Front Pharmacol. 2021 Apr 27;12:627693. doi: 10.3389/fphar.2021.627693. eCollection 2021. Front Pharmacol. 2021. PMID: 33986665 Free PMC article. Review. - Potential of Peptide Nucleic Acids in Future Therapeutic Applications.
Montazersaheb S, Hejazi MS, Nozad Charoudeh H. Montazersaheb S, et al. Adv Pharm Bull. 2018 Nov;8(4):551-563. doi: 10.15171/apb.2018.064. Epub 2018 Nov 29. Adv Pharm Bull. 2018. PMID: 30607328 Free PMC article. Review. - Bax inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal carcinoma cells.
Zhang M, Li X, Zhang Y, Zhou K. Zhang M, et al. Mol Cell Biochem. 2010 Jan;333(1-2):1-7. doi: 10.1007/s11010-009-0198-y. Epub 2009 Jul 5. Mol Cell Biochem. 2010. PMID: 19579059 - Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models.
Caldas-Lopes E, Cerchietti L, Ahn JH, Clement CC, Robles AI, Rodina A, Moulick K, Taldone T, Gozman A, Guo Y, Wu N, de Stanchina E, White J, Gross SS, Ma Y, Varticovski L, Melnick A, Chiosis G. Caldas-Lopes E, et al. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8368-73. doi: 10.1073/pnas.0903392106. Epub 2009 May 5. Proc Natl Acad Sci U S A. 2009. PMID: 19416831 Free PMC article. - The molecular genetics of breast cancer and targeted therapy.
Suter R, Marcum JA. Suter R, et al. Biologics. 2007 Sep;1(3):241-58. Biologics. 2007. PMID: 19707334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous